Page last updated: 2024-08-17

edetic acid and 1h-pyrrole-2,5-dione, 3-(1-methyl-1h-indol-3-yl)-4-(1-methyl-6-nitro-1h-indol-3-yl)-

edetic acid has been researched along with 1h-pyrrole-2,5-dione, 3-(1-methyl-1h-indol-3-yl)-4-(1-methyl-6-nitro-1h-indol-3-yl)- in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bissett, D; Breimer, L; Campbell, S; Cassidy, J; DeMario, M; Ritland, S; Salazar, R; Twelves, C; Zhi, J	1

Trials

1 trial(s) available for edetic acid and 1h-pyrrole-2,5-dione, 3-(1-methyl-1h-indol-3-yl)-4-(1-methyl-6-nitro-1h-indol-3-yl)-

Article	Year
A phase I clinical and pharmacokinetic study of Ro 31-7453 given as a 7- or 14-day oral twice daily schedule every 4 weeks in patients with solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-01, Volume: 10, Issue:13 Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Indoles; Male; Middle Aged; Models, Chemical; Neoplasms; Time Factors	2004

Article

Year

A phase I clinical and pharmacokinetic study of Ro 31-7453 given as a 7- or 14-day oral twice daily schedule every 4 weeks in patients with solid tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-01, Volume: 10, Issue:13

Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Indoles; Male; Middle Aged; Models, Chemical; Neoplasms; Time Factors

2004